Content area
Full Text
[Image omitted] - (http://www.fiercepharma.com/story/pfizer-plunk-down-190m-wrap-neurontin-class-action/2014-04-22)
In the latest settlement of a Big Pharma-delays-generics case, Pfizer ($PFE) has agreed to pay $190 million to wrap up a class-action suit over its seizure drug Neurontin . More than a decade old, the lawsuit claimed that Pfizer did some fast tap-dancing to prolong its Neurontin monopoly.
A group of Neurontin purchasers initially filed antitrust claims in 2002, saying that Pfizer's efforts to bat away generic versions cost them many millions of dollars. Among the steps Pfizer allegedly took to protect Neurontin from competition...